Qvents
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Individual
Company
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Excipients related
Qvents
1 minute read
Uncategorized
Home
Guidelines
Excipients related
Updated on May 22, 2025
Home
Guidelines
Excipients related
Updated on May 22, 2025
Excipient Risk Assessment (Europe)
:
Guidelines of 19 March 2015 on the formalised risk assessment for ascertaining the appropriate good manufacturing practice for excipients of medicinal products for human use ( EC 2015/C 95/02)
PIC/S Document:
Guidelines On The Formalised Risk Assessment For Ascertaining The Appropriate Good Manufacturing Practice For Excipients Of Medicinal Products For Human Use
EMA
:
Guideline On Excipients In The Dossier For Application For Marketing Authorisation Of A Medicinal Product
IPEC Europe
(International Pharmaceutical Excipients Council Europe)-
How to do document on European Commission Guidelines on the formalised risk assessment for ascertaining the appropriate good manufacturing practice for excipients of medicinal products for human use
IPEC-PQG
Good Manufacturing Practices Guide for Pharmaceutical Excipients (version 5, 2022).
IPEC Guidelines
IPEC Europe
(International Pharmaceutical Excipients Council Europe) –
Resources (on Pharmaceutical Excipients)
USFDA
Using the Inactive Ingredient Database (IID) Guidance for Industry
;
FDA Guidance
;
Search the IID
WHO
Good Manufacturing Practices for Excipients Used in Pharmaceutical Products (TRS 1060 – Annex 3)
Tags :
Excipients
Share:
Facebook
LinkedIn
Twitter
Search Posts
Latest Posts
Nitrosamine Impurities in Pharmaceutical Products: Templates for Risk Assessment and Supplier Evaluation
June 28, 2025
Supply Chain Traceability of Medicinal Products
May 31, 2025
Continuous Process Verification (CPV) and Evaluation Templates
May 16, 2025
Concerns of Beta-lactam Contamination Triggers Massive Recall by Glenmark
April 28, 2025
Excipient Risk Assessment: Approach, Templates
April 24, 2025